Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy

Biton, 2004, Zonisamide: newer antiepileptic agent with multiple mechanisms of action, Expert Rev Neurother, 4, 935, 10.1586/14737175.4.6.935 Brodie, 2005, Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures, Epilepsia, 46, 31, 10.1111/j.0013-9580.2005.14704.x Faught, 2001, Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures, Neurology, 57, 1774, 10.1212/WNL.57.10.1774 Sackellares, 2004, Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures, Epilepsia, 45, 610, 10.1111/j.0013-9580.2004.11403.x Schmidt, 1993, Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial, Epilepsy Res, 15, 67, 10.1016/0920-1211(93)90011-U Glauser, 2002, Zonisamide in pediatric epilepsy: review of the Japanese experience, J Child Neurol, 17, 87, 10.1177/088307380201700201 Kim, 2005, Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center, J Child Neurol, 20, 212, 10.1177/08830738050200030801 Ramsay, 2003, Zonisamide efficacy and safety stratified by patient age, Epilepsia, 44, 110